Biocon Limited has informed the Exchange regarding a press release dated November 07, 2020, titled "Biocon Biologics Receives USD 150 MillionCapital Injection from Goldman Sachs, Transaction Values Biocon Biologics at USD 3.94 Billion".
Biocon Limited has informed the Exchange regarding a press release dated November 07, 2020, titled "Biocon Biologics Receives USD 150 MillionCapital Injection from Goldman Sachs, Transaction Values Biocon Biologics at USD 3.94 Billion".